Medipharco Pharmaceutical Joint Stock Co
UUPCOM:MTP13,500.00
VND
+1,300.00
(+10.66%)
ISIN
VN000000MTP7
Return %
Stock
S&P 500
1Y
5.47
14.20
3Y
36.36
81.12
5Y
6.30
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- Hue Vietnam
- IPO Date
- Sep 23, 2010
- Similar Companies
- Business
- Medipharco Pharmaceutical Joint Stock Company is a Vietnam-based pharmaceutical enterprise primarily engaged in the research, manufacturing, processing, marketing, and distribution of finished pharmaceutical products, traditional herbal medicines, dietary supplements, medical consumables, cosmetics, and essential oils. Founded in 1976 and headquartered in Hue City, Vietnam, the company operates production, quality testing, and storage infrastructure compliant with Good Manufacturing Practice (GMP-WHO), Good Laboratory Practice (GLP), and Good Storage Practice (GSP) standards. Medipharco offers a diverse portfolio of over 150 commercial products across several specialized dosage forms and therapeutic classes, including topical preparations such as dermatological ointments, creams, and therapeutic gels; oral solid dosage forms including non-betalactam tablets, film-coated caplets, capsules, granules, and powders; antibiotic formulations, notably cephalosporin powders and capsules manufactured under licensing and franchise agreements; analgesic, antipyretic, and anti-inflammatory medications, including paracetamol-based lines; liquid pharmaceuticals consisting of oral syrups, therapeutic solutions, and ophthalmic and otic drops; traditional and phytotherapeutic remedies formulated from natural botanical extracts; and consumer healthcare goods, including dietary supplements, antiseptic cleansers, and cosmetic skincare items. The company distributes its products domestically across Vietnam through public healthcare tenders, hospitals, medical clinics, and retail pharmacy networks supported by regional branch offices in Hanoi and Ho Chi Minh City, while also exporting to international markets including Laos, Thailand, South Korea, Russia, Hungary, and select countries in Africa. In recent operational developments, Medipharco has strengthened its manufacturing integration following the consolidation of its Medipharco-Tenamyd joint venture operations, advanced capital investments into upgrading and building modern GSP-standard pharmaceutical warehouse facilities, and expanded its portfolio of high-demand generic pharmaceuticals and wellness products to support growing institutional and retail healthcare distribution channels.